Article in Molecular microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors.
Suellen Rodrigues MaranLaboratório de Biologia Molecular de Patógenos (LBMP), Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil.ORCID 0000-0003-0687-9186
Ariely Barbosa LeiteLaboratório de Biologia Molecular de Patógenos (LBMP), Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil.
Gabriela Gomes AlvesLaboratório de Biologia Molecular de Patógenos (LBMP), Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil.ORCID 0009-0008-0399-2929
Bruno Souza BonifácioLaboratório de Biologia Molecular de Patógenos (LBMP), Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil.ORCID 0000-0002-8501-4254
Carlos Eduardo AlvesLaboratório de Biologia Molecular de Patógenos (LBMP), Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil.
Paulo Otávio Lourenço MoreiraGrupo de Pesquisas Em Biotecnologia Aplicada Ao Estudo de Patógenos (BAP) - Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil.ORCID 0000-0002-6250-6854
Giovanna Marques PanessaDepartamento de Bioquímica, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.ORCID 0000-0002-5114-6187
Heloísa Monteiro do Amaral PradoCenter for Molecular Biology and Genetic Engineering (CBMEG), Center for Medicinal Chemistry (CQMED), Universidade Estadual de Campinas-UNICAMP, Campinas, Brazil.ORCID 0000-0001-6324-0579
Angélica Hollunder KlippelCenter for Molecular Biology and Genetic Engineering (CBMEG), Center for Medicinal Chemistry (CQMED), Universidade Estadual de Campinas-UNICAMP, Campinas, Brazil.ORCID 0000-0002-4376-6626
José Renato CussiolDepartamento de Bioquímica, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.ORCID 0000-0001-5909-8215
Katlin Brauer MassirerCenter for Molecular Biology and Genetic Engineering (CBMEG), Center for Medicinal Chemistry (CQMED), Universidade Estadual de Campinas-UNICAMP, Campinas, Brazil.ORCID 0000-0001-6390-2560
Tiago Rodrigues FerreiraLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.ORCID 0000-0003-4894-1515
David SacksLaboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA.
Clara Lúcia BarbiériDepartamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil.ORCID 0000-0001-9426-2308
Marcelo Santos da SilvaDepartment of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-4203-9299
Rubens Lima do Monte-NetoGrupo de Pesquisas Em Biotecnologia Aplicada Ao Estudo de Patógenos (BAP) - Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil.ORCID 0000-0002-4688-2462
Nilmar Silvio MorettiLaboratório de Biologia Molecular de Patógenos (LBMP), Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil.ORCID 0000-0003-0455-2497
Funding
Vector Biological Studies in LeishmaniasisZIAAI000256 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SACKS, DAVID · 2009 to 2025
$12.5M
Conselho Nacional de Desenvolvimento Científico e Tecnológico 312353/2023-5Conselho Nacional de Desenvolvimento Científico e Tecnológico 314103/2021-0Conselho Nacional de Desenvolvimento Científico e Tecnológico 424729/2018-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/09948-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2019/13765-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2020/02006-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2020/07870-4Fundação de Amparo à Pesquisa do Estado de São Paulo 2021/04867-5Fundação de Amparo à Pesquisa do Estado de São Paulo 2021/13477-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2021/13714-8Fundação de Amparo à Pesquisa do Estado de São Paulo 2022/03075-0Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/02323-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/16672-0Intramural NIH HHS ZIA AI000256NIAID NIH HHS
6 · The paper itself
Abstract
Leishmania presents a complex life cycle that involves both invertebrate and vertebrate hosts. By regulating gene expression, protein synthesis, and metabolism, the parasite can adapt to various environmental conditions. This regulation occurs mainly at the post-transcriptional level and may involve epitranscriptomic modifications of RNAs. Recent studies have shown that mRNAs in humans undergo a modification known as N4-acetylcytidine (ac4C) catalyzed by the enzyme N-acetyltransferase (NAT10), impacting mRNAs stability and translation. Here, we characterized the NAT10 homologue of L. mexicana, finding that the enzyme exhibits all the conserved acetyltransferase domains although failed to functionally complement the Kre33 mutant in Saccharomyces cerevisiae. We also discovered that LmexNAT10 is nuclear, and seems essential, as evidenced by unsuccessful attempts to obtain null mutant parasites. Phenotypic characterization of single-knockout parasites revealed that LmexNAT10 affects the multiplication of procyclic forms and the promastigote-amastigote differentiation. Additionally, in vivo infection studies using the invertebrate vector Lutzomyia longipalpis showed a delay in the parasite differentiation into metacyclics. Finally, we observed changes in the cell cycle progression and protein synthesis in the mutant parasites. Together, these results suggest that LmexNAT10 might be important for parasite differentiation, potentially by regulating ac4C levels.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Leishmania mexicana N-Acetyltransferease 10 Is Important for Polysome Formation and Cell Cycle Progression. · full record | OpenQuestion